Viking Therapeutics Gross Loans (Quarterly) Analysis

Viking Therapeutics, Inc. (VKTX)

33.75 -0.71 (-2.06%) USD | NASDAQ | Feb 24, 16:00

33.90 +0.15 (+0.44%) After-Hours: 07:30

View Gross Loans (Quarterly) for VKTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Gross Loans (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Gross Loans (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Gross Loans (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	--
Pfizer Inc.	--
Amgen, Inc.	--
Hims & Hers Health, Inc.	--
Regeneron Pharmaceuticals, Inc.	--